Showing results (71-80 of 490) with videos related to
Sort By:
Pageof 49
Biomed Research International|August 23, 2014
The effect of rilonacept versus placebo on health-related quality of life in patients with poorly controlled familial Mediterranean feverPhilip J Hashkes, Steven J Spalding, Rula Hajj-Ali, et al.Aquatic Toxicology (Amsterdam, Netherlands)|January 12, 2010
Silver nanospheres are cytotoxic and genotoxic to fish cellsJohn Pierce Wise, Britton C Goodale, Sandra S Wise, et al.The Journal of Rheumatology|September 3, 2014
Extension study of participants from the trial of early aggressive therapy in juvenile idiopathic arthritisCarol A Wallace, Sarah Ringold, John Bohnsack, et al.Annals of Internal Medicine|October 17, 2012
Rilonacept for colchicine-resistant or -intolerant familial Mediterranean fever: a randomized trialPhilip J Hashkes, Steven J Spalding, Edward H Giannini, et al.Trends in Plant Science|February 27, 2008
Plant ABC proteins--a unified nomenclature and updated inventoryPaul J Verrier, David Bird, Bo Burla, et al.The Journal of Rheumatology|October 17, 2009
The localized scleroderma skin severity index and physician global assessment of disease activity: a work in progress toward development of localized scleroderma outcome measuresThaschawee Arkachaisri, Soamarat Vilaiyuk, Suzanne Li, et al.Bioorganic & Medicinal Chemistry Letters|November 14, 2006
1,5-Biaryl pyrrole derivatives as EP1 receptor antagonists: Structure-activity relationships of 4- and 5-substituted benzoic acid derivativesAdrian Hall, Susan H Brown, Iain P Chessell, et al.Bioorganic & Medicinal Chemistry Letters|December 19, 2006
1,5-Biaryl pyrrole derivatives as EP1 receptor antagonists. Structure-activity relationships of 6-substituted and 5,6-disubstituted benzoic acid derivativesAdrian Hall, Susan H Brown, Iain P Chessell, et al.Bioorganic & Medicinal Chemistry Letters|April 12, 2018
Discovery of {4-[4,9-bis(ethyloxy)-1-oxo-1,3-dihydro-2H-benzo[f]isoindol-2-yl]-2-fluorophenyl}acetic acid (GSK726701A), a novel EP<sub>4</sub> receptor partial agonist for the treatment of painMark P Healy, Amanda C Allan, Kristin Bailey, et al.Bioorganic & Medicinal Chemistry Letters|May 16, 2006
Structure-activity relationships of 1,5-biaryl pyrroles as EP1 receptor antagonistsAdrian Hall, Stephen Atkinson, Susan H Brown, et al.Pageof 49